Publikationen M. Gernert

Hofmann, H., Korpjuhn, N., Laaguidi, S. F., MacKeigan, D., & Gernert, M. (2025). Continuous convection-enhanced delivery of the partial GABAA receptor agonist imepitoin into the rat subthalamic nucleus: antiseizure effects and comparison with acute systemic injections. In 10th German Pharm-Tox Summit 2025 (P060). https://doi.org/10.1007/s00210-025-03881-x
Details anzeigen

Lieneke, M., Laaguidi, S. F., & Gernert, M. (2025). Effects of the MAGL inhibitor MJN110 on acute seizure thresholds in rats. ZSN-Symposium, Hannover (Germany), 29.09.2025.
Details anzeigen

Lieneke, M., Laaguidi, S. F., & Gernert, M. (2025). Effects of the MAGL inhibitor MJN110 on acute seizure thresholds in rats. 34th VETPHARM-Symposium Berlin, 25.-26.09.2025.
Details anzeigen

Ottinger, M. C., Lieneke, M., Grannemann, L., & Gernert, M. (2025). Effects of the potassium channel opener azetukalner on seizure thresholds in rats. ZSN-Symposium, Hannover (Germany), 29.09.2025.
Details anzeigen

MacKeigan, D., Feja, M., & Gernert, M. (2024). Chronic intermittent convection-enhanced delivery of vigabatrin to the bilateral subthalamic nucleus in an acute rat seizure model. Epilepsy Research, 199, Article 107276. https://doi.org/10.1016/j.eplepsyres.2023.107276
Details anzeigen

Gernert, M., MacKeigan, D., Deking, L., Kaczmarek, E., & Feja, M. (2023). Acute and chronic convection-enhanced muscimol delivery into the rat subthalamic nucleus induces antiseizure effects associated with high responder rates. Epilepsy Research, 190, Article 107097. https://doi.org/10.1016/j.eplepsyres.2023.107097
Details anzeigen

MacKeigan, D., Feja, M., Meller, S., Deking, L., Javadova, A., Veenhuis, A., Felmy, F., & Gernert, M. (2023). Long-lasting antiseizure effects of chronic intrasubthalamic convection-enhanced delivery of valproate. Neurobiology of Disease, 187, Article 106321. https://doi.org/10.1016/j.nbd.2023.106321
Details anzeigen

Rohner, S., Gramer, M., Wiesweg, I., Scherf-Clavel, O., Wohlsein, P., Schmelz, M., Siebert, U., Richter, F., & Gernert, M. (2023). Present in the aquatic environment, unclear evidence in top predators: the unknown effects of anti-seizure medication on Eurasian otters (Lutra lutra) from northern Germany. Toxics, 11(4), Article 338. https://doi.org/10.3390/toxics11040338
Details anzeigen

Feja, M., Meller, S., Deking, L. S., Kaczmarek, E., During, M. J., Silverman, R. B., & Gernert, M. (2021). OV329, a novel highly potent γ-aminobutyric acid aminotransferase inactivator, induces pronounced anticonvulsant effects in the pentylenetetrazole seizure threshold test and in amygdala-kindled rats. Epilepsia, 62(12), 3091–3104. https://doi.org/10.1111/epi.17090
Details anzeigen

MacKeigan, D., Feja, M., Veenhuis, A., & Gernert, M. (2021). Intrasubthalamic vigabatrin delivery in an acute rat seizure model. In Stiftung Tierärztliche Hochschule Hannover (ed.), 14th Graduate School Days: 19/20 November 2021 : University of Veterinary Medicine, Institute for Pathology. Abstract book (ZSN P 07). 14th Graduate School Days, Hannover, 19.-20.11.2021. Stiftung Tierärztliche Hochschule Hannover.
Details anzeigen